These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2903237

  • 21. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M, Danek L, Smiałowski A.
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [Abstract] [Full Text] [Related]

  • 22. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM, Sun YF, Wang R, Ding YM, Zhang GY, Jin GZ.
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [Abstract] [Full Text] [Related]

  • 23. Determination of extracellular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs--studies using microdialysis.
    Dietze S, Kuschinsky K.
    J Neural Transm Gen Sect; 1992 Feb; 90(1):1-11. PubMed ID: 1361342
    [Abstract] [Full Text] [Related]

  • 24. Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum.
    Beggiato S, Borelli AC, Borroto-Escuela D, Corbucci I, Tomasini MC, Marti M, Antonelli T, Tanganelli S, Fuxe K, Ferraro L.
    Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
    [Abstract] [Full Text] [Related]

  • 25. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
    Plantjé JF, Daus FJ, Hansen HA, Stoof JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
    [Abstract] [Full Text] [Related]

  • 26. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E, Nahorski SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [Abstract] [Full Text] [Related]

  • 27. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes.
    Marchi M, Bocchieri P, Garbarino L, Raiteri M.
    Neurosci Lett; 1989 Jan 16; 96(2):229-34. PubMed ID: 2564654
    [Abstract] [Full Text] [Related]

  • 28. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G, Arnt J, Hyttel J.
    Eur J Pharmacol; 1988 Aug 24; 153(2-3):309-11. PubMed ID: 3053212
    [Abstract] [Full Text] [Related]

  • 29. Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release.
    Gorell JM, Czarnecki B, Hubbell S.
    Life Sci; 1986 Jun 16; 38(24):2247-54. PubMed ID: 2940433
    [Abstract] [Full Text] [Related]

  • 30. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens.
    White FJ, Wang RY.
    J Neurosci; 1986 Jan 16; 6(1):274-80. PubMed ID: 2868077
    [Abstract] [Full Text] [Related]

  • 31. Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.
    Saller CF, Salama AI.
    Eur J Pharmacol; 1985 Feb 26; 109(2):297-300. PubMed ID: 3873343
    [Abstract] [Full Text] [Related]

  • 32. Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study.
    Abraini JH, Fechtali T, Rostain JC.
    Brain Res; 1994 Apr 11; 642(1-2):199-205. PubMed ID: 8032880
    [Abstract] [Full Text] [Related]

  • 33. Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release.
    Gorell JM, Czarnecki B.
    Life Sci; 1986 Jun 16; 38(24):2239-46. PubMed ID: 2940432
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological activity profiles of dopamine D-1 and D-2 reception agonists and antagonists on striatal neuronal activity and the response to dexamphetamine in freely moving rats.
    Warenycia MW, McKenzie GM.
    Gen Pharmacol; 1989 Jun 16; 20(3):295-301. PubMed ID: 2568305
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
    Stamford JA, Kruk ZL, Millar J.
    Br J Pharmacol; 1991 Jan 16; 102(1):45-50. PubMed ID: 1675147
    [Abstract] [Full Text] [Related]

  • 36. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 37. Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.
    Kurata K, Shibata R.
    Neurosci Lett; 1990 Sep 18; 117(3):264-8. PubMed ID: 1982738
    [Abstract] [Full Text] [Related]

  • 38. D-1 type of dopamine autoreceptors are not involved in the regulation of dopamine synthesis in the striatum.
    Watanabe H, Suda H, Sekihara S, Nomura Y.
    Jpn J Pharmacol; 1987 Mar 18; 43(3):327-30. PubMed ID: 3495683
    [Abstract] [Full Text] [Related]

  • 39. Changes in motor activities induced by microinjections of the selective dopamine agonists LY 171555, quinpirole hydrochloride, and SK&F 38393 into the habenula nucleus.
    Thornton EW, Evans JA, Wickens A.
    Pharmacol Biochem Behav; 1987 Mar 18; 26(3):643-6. PubMed ID: 3495009
    [Abstract] [Full Text] [Related]

  • 40. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G, Bidzinski A, Fusi R, Ladinsky H, Consolo S.
    Life Sci; 1987 Oct 05; 41(14):1717-23. PubMed ID: 2958667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.